(0.58%) 5 076.00 points
(0.33%) 38 193 points
(0.81%) 17 580 points
(0.67%) $79.53
(2.33%) $1.977
(-0.18%) $2 306.90
(-1.15%) $26.44
(0.36%) $958.30
(0.15%) $0.934
(0.51%) $11.09
(0.08%) $0.799
(-1.49%) $91.87
Live Chart Being Loaded With Signals
Tongfang Kontafarma Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs and laboratory related products in Mainland China, Singapore, Taiwan, and the United States...
Stats | |
---|---|
Šios dienos apimtis | 6 000.00 |
Vidutinė apimtis | 531 310 |
Rinkos kapitalizacija | 178.52M |
EPS | HKD0 ( 2024-03-27 ) |
Last Dividend | HKD0.00400 ( 2013-05-27 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -3.20 |
ATR14 | HKD0 (0.00%) |
Tongfang Kontafarma Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Tongfang Kontafarma Finansinės ataskaitos
Annual | 2023 |
Pajamos: | HKD809.11M |
Bruto pelnas: | HKD464.54M (57.41 %) |
EPS: | HKD-0.00520 |
FY | 2023 |
Pajamos: | HKD809.11M |
Bruto pelnas: | HKD464.54M (57.41 %) |
EPS: | HKD-0.00520 |
FY | 2022 |
Pajamos: | HKD894.06M |
Bruto pelnas: | HKD506.22M (56.62 %) |
EPS: | HKD-0.0197 |
FY | 2021 |
Pajamos: | HKD961.09M |
Bruto pelnas: | HKD482.89M (50.24 %) |
EPS: | HKD-0.00270 |
Financial Reports:
No articles found.
Tongfang Kontafarma Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
First Dividend | HKD0.00400 | 2012-05-28 |
Last Dividend | HKD0.00400 | 2013-05-27 |
Next Dividend | HKD0 | N/A |
Payout Date | 2013-06-13 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | HKD0.00800 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.18 | -- |
Div. Sustainability Score | 4.38 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 2.18 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2368.HK | Ex Dividend Knight | 2023-08-25 | Semi-Annually | 0 | 0.00% | |
1357.HK | Ex Dividend Junior | 2023-06-05 | Insufficient data to determine frequency | 0 | 0.00% | |
0398.HK | Ex Dividend Knight | 2023-09-29 | Semi-Annually | 0 | 0.00% | |
6690.HK | Ex Dividend Knight | 2023-07-24 | Annually | 0 | 0.00% | |
1905.HK | Ex Dividend Knight | 2023-10-20 | Semi-Annually | 0 | 0.00% | |
0934.HK | Ex Dividend Knight | 2023-09-14 | Semi-Annually | 0 | 0.00% | |
0057.HK | Ex Dividend Knight | 2023-09-01 | Semi-Annually | 0 | 0.00% | |
2885.HK | Ex Dividend Junior | 2023-06-15 | Annually | 0 | 0.00% | |
1501.HK | Ex Dividend Junior | 2023-05-24 | Annually | 0 | 0.00% | |
0552.HK | Ex Dividend Junior | 2023-07-03 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0356 | 1.500 | -0.713 | -1.069 | [0 - 0.5] |
returnOnAssetsTTM | -0.0250 | 1.200 | -0.835 | -1.002 | [0 - 0.3] |
returnOnEquityTTM | -0.0397 | 1.500 | -1.553 | -2.33 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.516 | 0.800 | 7.42 | 5.94 | [1 - 3] |
quickRatioTTM | 1.140 | 0.800 | 8.00 | 6.40 | [0.8 - 2.5] |
cashRatioTTM | 0.202 | 1.500 | 9.99 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0686 | -1.500 | 8.86 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -14.97 | 1.000 | -6.66 | -6.66 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.000422 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.00431 | 2.00 | -0.00215 | -0.00431 | [0 - 20] |
debtEquityRatioTTM | 0.112 | -1.500 | 9.55 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.577 | 1.000 | 3.72 | 3.72 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.203 | 1.000 | -6.06 | -6.06 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0199 | 1.000 | -1.001 | -1.001 | [0.2 - 2] |
assetTurnoverTTM | 0.703 | 0.800 | 8.65 | 6.92 | [0.5 - 2] |
Total Score | 4.38 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -4.13 | 1.000 | -0.518 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0397 | 2.50 | -0.998 | -2.33 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.00431 | 2.00 | -0.00144 | -0.00431 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.000422 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0316 | 1.500 | -3.12 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.00194 | 1.000 | -2.45 | 0 | [0.1 - 0.5] |
Total Score | -0.0152 |
Tongfang Kontafarma
Tongfang Kontafarma Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs and laboratory related products in Mainland China, Singapore, Taiwan, and the United States. The company operates in Pharmaceutical Business and Fitness Business segments. It also offers chemical drugs and prescribed traditional Chinese medicines; operates fitness centers; operates in the franchise business; and provides consultation services for fitness and health activities. The company trades in laboratory related products; researches and develops medical products; and offers corporate advisory services. As of December 31, 2021, it operated 12 fitness centers and 2 yoga center in Taiwan; and 10 fitness centers in Singapore. The company was formerly known as Allied Cement Holdings Limited and changed its name to Tongfang Kontafarma Holdings Limited in August 2016. The company was founded in 1993 and is headquartered in Wan Chai, Hong Kong. Tongfang Kontafarma Holdings Limited is a subsidiary of China Health Management Investment Limited.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.